Advanced pneumonic type of lung adenocarcinoma: survival predictors and treatment efficacy of the tumor.

CONCLUSION: TKI-based therapy could improve the prognosis and OS for advanced P-ADC. This study recommends the analysis of EGFR mutations for all patients with advanced P-ADC. PMID: 32762285 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research